PEP-Therapy SAS is a medical biotechnology company, which develops targeted therapies for severe diseases having high medical needs, with an initial focus on cancers.

PEP-Therapy operates a Cell Penetrating and Interfering Peptides (CP&IP) technology for the development of its therapeutic products. These innovative molecules penetrate cells then specifically block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.